Scroll down

Invention

The invention provides for a method to effectively deliver mutagenic nucleobases to plant cell protoplasts using polyethylene glycol (PEG).

Benefit

Genome editing technologies are rapidly emerging. Many targeted genome editing technologies require the (co-)transfection of single stranded oligonucleotides designed to direct the repair of a mutation of interest. The patented technology ensures optimal survival efficiencies of oligonucleotide transfected protoplasts, thereby increasing the chance of regenerating plants from edited protoplasts.

Vision

Efficient targeted genome editing technologies are important research tools in gene validation and may be used for introduction of new traits in crop germplasm. By improving survival of edited protoplast the present invention contributes thereto.

Patent

Click on the link for an overview of the patent family in the European Patent Register: WO2009/082190

Please note that the European Patent Register may not be extensive and/or accurate, for which KeyGene is not responsible. Please contact your patent expert for further information.

Contact us

Would you like to explore the possibilities for obtaining a license for this technology? You can contact our licensing team by mail.

Would you like to know more about our technologies and licensing possibilities? Visit our webpage about Licensing KeyGene’s proprietary technologies.